Positron emission tomography (PET) using the radiolabeled glucose analogue 18F-FDG allows uncovering glycolysis processes within cancer cells and reveals high value in diagnosis, staging, relapse and therapeutic response evaluation in several malignancies. Breast cancer presents considerable variability when it comes to 18F-FDG uptake, which results in different sensitivity and specificity valu...

UNLABELLED The clinical utility of 18F-FDG PET in evaluating salivary gland malignancies has not been well defined. We therefore evaluated the utility of 18F-FDG PET in management for patients with salivary gland cancers. METHODS Thirty-four patients with newly diagnosed salivary gland cancers underwent CT and 18F-FDG PET before surgical resection with radiotherapy. The diagnostic accuracies ...

Objective. Assessing the level of anxiety in oncology patients who underwent 18F-FDG PET/CT low dose scan and identifying the main reasons that generate anxiety. Material and Method. The study included 81 cancer patients submitted to the 18F-FDG PET/CT low dose scan. Patients filled in the Scan Experience Questionnaire and the State-Trait Anxiety Inventory (STAI) before and after 18F-FDG PET/CT...

Background: The role of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in the surgical approach solitary pulmonary nodule (SPN) is still debated, as increased metabolic avidity lesion was not a sure sign malignancy. purpose this study to evaluate effectiveness 18F-FDG-PET/CT characterization SPN based on analysis most recent data literature.

Dear Editor, A 40-year-old female presented acutely with syncope and recurrent ventricular tachycardia (VT) requiring repeated cardioversion. Transthoracic echocardiogram (TTE) revealed mildly depressed systolic function of 40% to 45% with normal right ventricular size and function. Coronary angiogram revealed insignifi cant coronary artery disease (CAD). Biopsy of enlarged mediastinal lymph no...

Whole-body imaging with Positron Emission Tomography (PET) using F-18 Fluorodeoxyglucose (18F-FDG) has been widely used along the evaluation and clinical management of neoplasms. The main advantage whole-body 18F-FDG PET in oncology is ability to detect unexpected or incidental tumor sites. purpose this study was determine incidentaloma examination nuclear medicine. This research uses literatur...

An observational study was set up to assess the feasibility of [18F]FPRGD2 PET/CT for imaging patients with multiple myeloma (MM) and to compare its detection rate with low dose CT alone and combined [18F]NaF/[18F]FDG PET/CT images. Four patients (2 newly diagnosed patients and 2 with relapsed MM) were included and underwent whole-body PET/CT after injection of [18F]FPRGD2. The obtained images ...

A 58-year-old woman with bilateral lower limb varicose veins and Burkitt lymphoma underwent positronemission tomography/computed tomography (PET-CT) to exclude lymphoma relapse. PET-CT images did not show any suspicious lesion suggestive of malignancy. However, intense 18F-fluorodeoxyglucose (FDG) uptake focus was detected in the left lung without a corresponding CT abnormality. Follow-up PET-C...

This article provides a brief overview of the 18F isotope production using Cyclone-30 cyclotron and two liquid targets with volume 0.5 2.0 ml, water enriched 18O was used as target material. The obtained for serial [18F]FDG radiopharmaceutical supply this medicine to operating PET centers in Almaty. also experimental syntheses [18F]PSMA-1007 Na[18F]F assess possibility implementation these medi...

A residual mass after treatment of lymphoma is a clinical challenge, because it may represent vital tumor as well as tissue fibrosis. Metabolic imaging by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) offers the advantage of functional tissue characterization that is largely independent of morphologic criteria. We compared 18F-FDG PET to computed tomography (CT) in the pos...